DCT
1:18-cv-01288
Valeant Pharma Intl v. Actavis Laboratories FL Inc
Log In
Overview
Analysis
General
Parties
Attorneys
Patents
Related Cases
Dockets
General
Filed
08/22/18
Cause of Action
Infringement
Sector
Biotech
Status
Closed (03/29/21)
Patent Owner
NPE
(L)
Source
PACER
Appeals
20-1201
Court
D. Delaware
Judge
Period
PO Win Rate
Leonard P. Stark
08/24/18 - 12/16/21
40%
Magistrate
Christopher J. Burke
Plaintiff
Party
Name
Ratings
Valeant Pharmaceuticals Intl Inc
NPE
L3
A
Salix Pharmaceuticals Ltd
NPE
L4
A
Cosmo Technologies Ltd
L3
C
Show all (1 more)
Attorney
Name
Ratings
Morris Nichols Arsht & Tunnell LLP
Local
L5
A
Jack B. Blumenfeld
L5
A
Michael J. Flynn
L4
B
McDermott Will & Emery LLP
L5
C
Paul M. Schoenhard
L5
B
Thomas P. Steindler
L5
E
Christopher Bruno
L4
E
Sami Sedghani
L4
E
Veltrop & Harkrider LLP
L3
E
William C. Rose
L1
D
Show all (0 more)
Defendant
Party
Name
Ratings
Actavis Laboratories FL Inc
L5
E
Teva Pharmaceuticals USA Inc
L5
E
Teva Pharmaceutical Industries Ltd
L5
E
Actavis Pharma Inc
L3
E
Show all (2 more)
Attorney
Name
Ratings
Goodwin Procter LLP
L4
D
Samuel Sherry
L5
B
John T. Bennett
L5
C
Elizabeth K. Chang
L5
E
Todd Marabella
L4
D
Shaobo Zhu
L2
D
Phillips Goldman McLaughlin & Hall PA
Local
L4
E
John C. Phillips, Jr.
L5
E
David A. Bilson
L4
E
Show all (-1 more)